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Introduction
Leprosy (Hansen's Disease) is primarily a disease of peripheral nerves and skin but also affects bones. In the multi-bacillary lepromatous state there is direct invasion of soft tissues around the face and mouth by Mycobacterium leprae and spread via the peripheral nerves to the long bones and extremities. These changes in physical characteristics enabled the disease to be recognised in antiquity (Skinses and Chang, 1985) . Although diagnoses based only on written reports remain questionable, they suggest that leprosy existed in ancient times in Egypt, India and China (Lechat, 1999; Mark, 2002) . There is possible skeletal evidence of leprosy from 2000 BC Rajasthan and the late Indus civilisation from 2500-1700 BC (Robbins Schug et al., 2013) . The most diagnostic bone changes are found in the skull, described as the rhinomaxillary syndrome, that involves the destruction of the anterior nasal spine, the rounding and widening of the nasal margins, the partial resorption of the pre-maxillary alveolar process and in some cases the loss of the upper incisors (Møller-Christensen, 1961; Ortner, 2003) . Additional changes include deformities of the hands and feet, which are usually symmetrical and involve joint destruction, resorption of the fingers and toes, with potentially partial dislocation and bone fusion (Ortner, 2003) A major difficulty in diagnosing leprosy in skeletal remains is that syphilis may cause similar changes in the rhinomaxillary region, while psoriatic arthritis, septic arthritis and other joint diseases may cause identical changes in the hands and feet (Ortner and Putschar, 1985) . Hence a clear diagnosis of leprosy based solely on paleopathology can be made only if the typical facial changes are found in combination with atrophy and truncation of the fingers and toes. Not all leprosy cases display changes in both the rhinomaxillary region and the hands and feet, making paleopathological diagnosis difficult. Furthermore, as skeletal collections often comprise incomplete and damaged bones, paleopathological diagnosis is likely to overlook many true leprosy cases due to insufficient evidence. As M. leprae is an obligate pathogen, its presence in ancient human remains provides clear evidence of infection (Donoghue et al., 2002) . Ancient DNA (aDNA) and/or lipid biomarker analyses enable identification of M. leprae, thereby confirming the antiquity of the disease. If aDNA preservation is sufficient, phylogenetic data may be obtained, but analysis is often restricted to the confirmation of probable leprosy cases, identified by paleopathological features.
Only about 5% of lepromatous leprosy, diagnosed in the 20 th century before the introduction of antibiotics, involved bone changes (Faget and Mayoral, 1942) . Therefore, the number of leprosy cases diagnosed by paleopathology will always be an under-estimate.
However, comparison of the number of leprosy cases based on paleopathology against the number of skeletons systematically examined for typical lesions for a given period in antiquity, gives a glimpse of changes in the prevalence rates of the disease over space and time. In Britain the earliest evidence of leprosy was found in 2/1480 specimens from Romano-British sites (0.14% prevalence), in 18/2031 specimens from the 5 th -11 th centuries AD (0.89% prevalence) and in 108/4742 specimens dated from the 12 th -16 th centuries (2.28% prevalence) (Roberts, 2002) . This is consistent with the historical accounts and suggests that the earliest appearance of the disease in Europe occurred during the Roman period (Pinhasi et al., 2006) .
A major historic transition occurred when early Eurasian civilizations came into military and commercial contact some 1500-3000 years ago (McMichael, 2001; 2004 Mark (2002) suggested that the troops of Alexander the Great brought leprosy from eastern Asia to the Mediterranean, leading to its spread on a larger scale in Europe during the fourth century BC.
Skeletal cases with evidence of pathological lesions that are consistent with leprosy were reported from 4 th -3 rd century BC Bologna, Italy and 2 nd century BC Roman Egypt (Molto, 2002) . A case of lepromatous leprosy from mummified remains in early Christian Nubia (Elliot Smith and Dawson, 1924) and there are several reported cases from the Byzantine period (Zias, 1985) . A child with characteristic leprosy paleopathology was found in Martellona (Rome, Central Italy), dated to the 2 nd -3 rd century AD (Rubini et al., 2012 ). An adult from Palombara, a poor rural site near Rome, Central Italy, showed paleopathology of the rhinomaxillary region typical of leprosy (Rubini et al., 2014) . This case was C 14 -dated to 475 ± 25 years CE (5 th century AD). Among other early cases, Reader (1974) reported changes suggestive of leprosy in the right foot of an incomplete adult skeleton from a 4 th century AD Romano-British cemetery. Also, a case from the Roman Iron Age (0-400 AD) has been reported in Sweden (Arcini and Artelius, 1993 cited by Kjellström, 2010) . Hence, there is sporadic evidence of leprosy in the 'Roman World' that may have extended west to southern Britain and north to southern Sweden.
The diagnosis of M. leprae in specimens using both paleopathological diagnosis and aDNA analysis was first reported by Rafi et al. (1994) in archaeological skeletal samples from early Christian Palestine (600 AD). The earliest case confirmed by aDNA analysis, also from the Eastern Mediterranean, was dated to the 1st century AD (Donoghue et al., 2005a; Matheson et al., 2009 ). The M. leprae genome contains several repetitive sequences that enable the identification of the organism. Single nucleotide polymorphisms (SNPs) form the basis of molecular typing (Monot et al., 2005 ). There appears to be a clonal relationship between M. leprae and its human host, so determination of the genetic profiles of modern and extinct strains of M. leprae can illuminate the migration and spread of pathogen and host over time Economou et al., 2013; Schuenemann et al., 2013; Taylor et al., 2013; Mendum et al., 2014) . Archaeological studies indicate that the first significant appearance of leprosy occurred in northern Europe during the 9 th -11 th century AD (Schuenemann et al., 2013; Taylor et al., 2013) . In Britain, the increase of lazar house foundations for the care of leprosy patients was maximal during the 12 th and early 13 th centuries (Manchester and Roberts, 1989) . During the 15 th -16 th centuries the disease nearly disappeared from southern Europe and Britain, possibly linked to the increased level of tuberculosis in the community (Manchester, 1984) .
Much less is known about the appearance and spread of leprosy in Eastern Europe and Western Asia. The paleopathological study by Blau & Yagodin (2005a) indicates evidence of leprosy from a nomadic burial mound located in the Ustyurt Plateau, Uzbekistan, radiocarbon dated to 80-240 AD (OxA-11792 on human tooth, 2 sigma) (Blau and Yagodin, 2005b) . This suggests that leprosy prevailed among nomadic central Asian people and that one or more of these Asian populations may have either introduced leprosy for the first time in Eastern Europe by the 6-8 th century AD, or possibly re-introduced it as a later wave following the Roman period spread of the disease across Europe. However, there is a lack of evidence of leprosy from the skeletal population in the eastern parts of the Roman Empire, such as Croatia, where the earliest historical report of the disease was 804 AD and linked to contact with Byzantium (Bakija-Konsuo and Mulić, 2011).
The movement of peoples from Central Asia into the Great Hungarian Plain (Holló et al., 2008) and Northern Italy (Rubini and Zaio, 2011 ) may be relevant in relation to the spread of leprosy. Cases recognised by paleopathology were reported from cemeteries in 6 th -8 th century Central Italy Rubini and Zaio, 2009 ) and from a 10 th century cemetery in Eastern Hungary (Palfí, 1991) . Later, combined paleopathological and aDNA studies of specimens from early medieval sites in Eastern Hungary (Haas et al., 2000;  existed in Eastern Europe during this period.
A key to our understanding of spatio-temporal changes in disease patterns is the identification of new leprosy cases from well-dated archaeological contexts and their differential diagnosis, using both paleopathological and molecular methods (Donoghue et al., 2005a; Minnikin et al., 2011) . The present study focuses on the confirmation of leprosy in Northern Anatolia, Eastern and Central Europe, during the 6 th -11 th centuries AD and the molecular characterisation of M. leprae. This was achieved by collating earlier results and systematically assessing the presence of leprosy in eight Avar period cemeteries, six Early
Mediaeval sites, and a Byzantine North Anatolian cemetery.
Materials and Methods

Paleopathological assessment
Specimens analyzed originated from Austria, the Czech Republic, Hungary, Italy and Turkey, dated from the 6 th -8 th to the 11 th centuries (Table 1) . Further details and descriptions of the additional archaeological sites and burials are available as electronic supplementary material S1. Possible leprosy cases were first identified according to established paleopathological signs (S1 supplementary text and figures) and were assessed using standard macroscopic methods.
Molecular analysis
Taking strict precautions against contamination (supplementary material S2), DNA extracts were made for all specimens with pathological conditions consistent with infection by the pathogen. M. leprae multi-copy and single-copy loci were amplified by PCR, with independent laboratories to provide verification of data, using established methods for paleomicrobiological analysis (S2 Table 1 ) based on the repetitive sequences RLEP (Donoghue et al., 2001; Taylor et al., 2011) and RepLep. Better-preserved samples were genotyped (Monot et al., 2005) according to three single nucleotide polymorphisms (SNPs) and sub-genotyped, where possible Taylor et al., 2006; .
Strains were further distinguished by microsatellite analysis (Taylor and Donoghue, 2011; Taylor et al., 2013) . M. leprae cell wall lipid biomarkers (supplementary text and figures S3)
were used to provide independent confirmation of aDNA findings (Redman et al., 2009; Lee et al., 2012) . Several specimens were also examined for the presence of M. tuberculosis aDNA (supplementary text and Table S2 ).
Results
A detailed paleopathological macroscopic analysis of putative leprosy cases, together with an assessment of published cases, identified material for molecular examination (supplementary text and figures S1). M. leprae DNA was found in specimens at all sites, including seven from Hungary, two sites from Italy, and one site each from Austria, the Czech Republic and Turkey (Table 1) . The timescale ranged from the 6 th -8 th to the 11 th centuries. In several specimens M. tuberculosis aDNA was also detected, confirming earlier findings of such co-infections (Donoghue et al., 2005a) .
Genotyping was successfully performed for M. leprae DNA (supplementary text and figures S2) obtained from 7 th century Hungary, 8 th -9 th century Turkey, 9 th -10 th century Czech Republic and 10 th century Hungary. All were of SNP-type 3. This is associated in the modern day with strains from Europe, North Africa, the Far East and the Americas (Monot et al., 2005 Weng et al., 2013) . Where sub-genotyping was possible, the Hungarian and Byzantine samples from the 7 th -10 th centuries were of subtype 3K. Two samples, from 9 th -10 th century Czech Republic and 10 th century Hungary were of subtype 3M (Table 1) .
Two samples from Hungary, from the 10 th century, plus one sample from the Czech Republic (9 th -10 th century), each yielded unique microsatellite data that indicates the excellent state of preservation of these specimens (Taylor and Donoghue, 2011) . The M.
leprae DNA from the two individuals in the adjoined Hungarian burial site of Püspökladány-Eperjesvölgy differed in the number of TTC repeats, having 12 and 17 copies respectively.
Interestingly, these two 10 th -century M. leprae strains were of different sub-genotypes, 3K and 3M. Therefore, different sub-genotypes of M. leprae were contemporaneous in the same burial ground. This has also been noted in burial grounds from North West Europe, where individuals with M. leprae genotypes 2F or 3I were identified Taylor et al. 2013) .
M. leprae cell wall lipids appear to be more persistent than aDNA, as shown by the data from 7 th century Vicenne, Italy, where no aDNA but lipid biomarkers were found in a well-developed case of leprosy in specimen 144 (Table 1 and supplementary text and figures   S3 ). Strong, coherent profiles of total mycolic acids were recorded for specimens 18R, 18L
and 144, but they differed slightly from the modern M. leprae standard (S3 Fig. 1 ). The profiles of the purified α-mycolates were again coherent, but the overall profiles were essentially four carbons shorter than those from standard M. leprae (S3 Fig. 2) . In contrast, the more robust mycocerosates showed an excellent profile of C 30 to C 34 mycocerosates for specimen 18R (S3 Fig. 3 ), corresponding closely with the M. leprae standard (S3 Fig. 4) . The same mycocerosates, typical of M. leprae, were seen for 18L and 144, but with much reduced intensity (S3 Fig. 3 ).
Discussion
Geographical analysis shows that regions, apparently endemic for leprosy, are associated with migrations linked with military activity and aggressive expansion of territories, or of colonization (Buzhilova, 2002) . Early sporadic reports of leprosy in Western Europe (Manchester, 1984; Lechat, 1999; Brothwell et al., 2000; Blondiaux et al., 2002) are believed to be associated with Roman armies and traders. The premise that leprosy originated in the East and came to Egypt via seaborne trade during this period is discussed by Mark (2002) who thought that this was more likely than the widely-held belief that the disease was brought back by the armies of Alexander the Great (Dols, 1979; Monot et al., 2005) . After the fall of the Roman Empire there was an expansion westwards of peoples from Central Asia. The Avars, believed to belong to the Juan-Juan confederation of Mongolian pastoralist tribes, emerged in the 4th century AD (Zhang and Rong, 1998) and spread into Eastern and Central Europe (Fig. 1 ). Diagnosis of leprosy in 1 st -4 th century AD Uzbekistan (Blau and Yagodin, 2005a,b) , using paleopathology and subsequent molecular analysis ), demonstrates the antiquity of leprosy in Central Asia and suggests that the disease could have been spread by the Avars, resulting in the appearance of leprosy in Hungary, Eastern Austria and Italy. Another possibility is that the Avars played a role in the spread of indigenous leprosy from Asia Minor to Eastern and Central Europe. Leprosy was a disease known in Byzantium (Dols, 1979 ) and a gold Byzantine solidus was recovered from Grave 21 in Kiskundorozsma-Daruhalom, Hungary. This represents the latest coin of the series issued under Constans II (Constans II, MIB 39, AD 667-668). Thus there is circumstantial evidence to suggest that males of this Avar community had contacts with the Byzantine Empire (Donoghue et al., 2005b) . This coin was probably minted for about a year, and it is thus reasonable to assume that the journey occurred sometime in the late AD 660's or early AD 670's.
Following their arrival in the Byzantine Empire and southeast Europe, the Avars migrated westwards and clashed with the kingdom of the Franks. There is both historical and archaeological evidence of Avar occupation in the area at this time, and that they formed alliances with local Slavs. The case from the 9 th century Czech Republic (Taylor and Donoghue, 2011) is relevant as it is from the Slavic Greater Moravian Empire, known to have fought both alongside and against the Avars, thereby providing means of spread of the disease. The confirmation of several cases of leprosy identified by skeletal paleopathology, reported from 7 th -9 th century AD Avar settlements in Hungary Palfí and Molnár, 2009) , is the earliest report of the disease in this region. Similarly, the finding of M. leprae DNA in an 8 th -9 th century Austrian sample pre-dates all other known cases of leprosy in that country.
Leprosy has also been found in 6 th -8 th century Italy. The leprosy case from the 7 th century cemetery of Vicenne-Campochairo, Italy was from a Barbarian complex with Lombard, local and Asian grave goods . Rubini & Zaio (2009) described two burials with leprosy paleopathology in a cemetery attributed to a semi-nomadic Lombard-Avar group. Both sites may have represented military outposts to control the area against Byzantine invasions. The present biomolecular study confirms M. leprae at both sites.
The molecular confirmation of M. leprae in 8 th -9 th century Croatia (Watson et al., 2009 ) is consistent with the earliest historical report of leprosy at this location in 804 AD (Bakija-Konsuo and Mulíc, 2011), especially as it is suggested that the disease resulted from contact with Byzantium.
A 4th century sample from the Dakhleh Oasis in Roman Egypt was of genotype 3 (Monot et al., 2005) , the same main branch as those linked to the Avar expansion, although it was not possible to determine the sub-genotype. The earliest M. leprae to be sub-genotyped, from 1 st -4 th century Uzbekistan, was of subtype 3L (Taylor and Donoghue, 2011) . It is of interest that the predominant sub-genotype in the earlier Hungarian samples was 3K, identical to the leprosy found in Byzantine Anatolia (Table 1 ) and the main sub-genotype found today in Turkey and the near East . Two Hungarian samples from the 9 th and may form a separate branch of the M. leprae phylogenetic tree (Schuenemann et al, 2013) , termed branch 0. However, that study was primarily based on strains from Northern and Western Europe, and included only two 3K strains that were from modern China and New
Caledonia. Therefore, further work is needed to clarify the phylogeny of the type 3 subgenotypes. Overall, our biomolecular diagnosis of early cases of leprosy from Hungary, Austria, the Czech Republic, Italy, Croatia, and Turkey suggests that the migration of the Avars from Central Asia into Byzantium and Central Europe was associated with a further wave of leprosy in local populations not previously exposed to the disease.
The few sub-genotypes obtained from Northern and Western Europe are 3I or 2F Schuenemann et al., 2013; Taylor et al., 2013; Mendum et al., 2014) .
These genotypes are from at least two lineages that were associated with the Mediaeval rise in leprosy described in North West Europe and appear to be associated with Nordic and Saxon populations. However, more work is needed to confirm this. The 3I lineage is of special interest as it has been reported in a later medieval burial ) and is still found in the southern states of the USA (Truman et al., 2011) , whence it was probably carried by early European settlers.
The subsequent decline of leprosy in Western Europe cannot readily be explained.
Recent analyses of whole genomes retrieved from several European archaeological sites and their comparison with modern isolates (Schuenemann et al., 2013) patrons and physicians. Under such conditions, the suggestion has arisen that a subsequent improvement in socio-economic conditions, coupled with the innate resistance of the surviving population, resulted in a shift to the tuberculoid end of the disease spectrum in those exposed to leprosy (Manchester, 1984) . Additionally, it is probable that the increased urbanisation and population density that occurred from the late 15 th century resulted in tuberculosis killing leprosy patients (Donoghue et al., 2005a) . Either of these two factors could break the transmission of infection. Epidemiological analysis shows that both theories are feasible (Hohmann and Voss-Böhme. 2013 ).
In conclusion, the genotyping data currently available support the suggestion that different M. leprae strains from Central Asia or Asia Minor were introduced into Europe during the early medieval period, associated with the westward migration of Avars. However, more evidence is needed to determine whether microbial virulence or host factors were responsible for the subsequent large rise in the incidence of leprosy in Europe and its subsequent decline.
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Figure 1
Location of archaeological sites listed in Table 1 .
Table 1
Summary of age and geographical location of burial sites, details of specimens examined and molecular biomarkers detected. 
Highlights
· 32 skeletal remains from 16 sites in 7 countries had physical evidence of leprosy · 26 individuals harbored Mycobacterium leprae ancient DNA and/or lipid biomarkers · Avars from Central Asia were linked with 6 th -8 th century European leprosy burials · We confirmed the earliest known leprosy cases in Southern Hungary and Austria · Ancient DNA showed that six individuals had leprosy co-infected with tuberculosis
